BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12904899)

  • 1. Decreased expression of membrane alpha4beta1, alpha5beta1 integrins and transferrin receptor on erythroblasts in splenectomized patients with beta-thalassemia intermedia. Parallel assessment of serum soluble transferrin receptors levels.
    Kossiva L; Paterakis G; Tassiopoulos S; Papadhimitriou SI; Voukouti E; Gligori I; Rombos Y
    Ann Hematol; 2003 Sep; 82(9):579-84. PubMed ID: 12904899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study on thalassemic erythroid precursors in liquid culture.
    Khuhapinant A; Bunyaratvej A; Sahaphong S; Pattanapanyasat K; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():82-92. PubMed ID: 9640605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D; Gross A; Kosova N; Fichtner I; Salama A
    Transfusion; 2005 Jul; 45(7):1192-200. PubMed ID: 15987366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.
    Skarmoutsou C; Papassotiriou I; Traeger-Synodinos J; Stamou H; Ladis V; Metaxotou-Mavrommati A; Stamoulakatou A; Kanavakis E
    Haematologica; 2003 Jun; 88(6):631-6. PubMed ID: 12801838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of erythropoietin and soluble transferrin receptor in the course of pregnancy in non beta thalassemic and beta thalassemic women.
    Bianco I; Mastropietro F; D'Asero C; Graziani B; Piergrossi P; Mezzabotta M; Modiano G
    Haematologica; 2000 Sep; 85(9):902-7. PubMed ID: 10980626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-thalassemia and sickle cell disease in culture of early erythroid precursors: hemoglobin synthesis and ultrastructural study.
    Beuzard Y; Tulliez M; Testa U; Vainchenker W; Dubart A; Tsapis A; Galacteros F; Breton-Gorius J; Rosa J
    Blood Cells; 1981; 7(1):179-200. PubMed ID: 7187747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of integrins by hematopoietic cells in patients with rheumatoid arthritis and anemia: relationship with bone marrow cytokine levels.
    Jaworski J; Maslinski W; Pazdur J; Sliwinska-Stanczyk P; Kaminska-Tchorzewska E; Jung L; Lacki JK
    J Investig Allergol Clin Immunol; 2008; 18(1):17-21. PubMed ID: 18361097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum erythropoietin and circulating transferrin receptor in thalassemia intermedia patients with heterogeneous genotypes.
    Camaschella C; Gonella S; Calabrese R; Vischia F; Roetto A; Graziadei G; Mazza U; Cappellini MD
    Haematologica; 1996; 81(5):397-403. PubMed ID: 8952151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum transferrin receptor concentration and its ratio to bone marrow erythroblasts in iron deficiency anemia and anemia of chronic diseases.
    Choi JW
    Ann Clin Lab Sci; 2007; 37(3):288-90. PubMed ID: 17709697
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced activation of autophagy in β-thalassemia/Hb E erythroblasts during erythropoiesis.
    Lithanatudom P; Wannatung T; Leecharoenkiat A; Svasti S; Fucharoen S; Smith DR
    Ann Hematol; 2011 Jul; 90(7):747-58. PubMed ID: 21221583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble transferrin receptor following bone marrow transplantation from donors heterozygous for beta thalassemia.
    Centis F; Delfini C; Agostinelli F; Tonucci P; Gaziev J; Annibali M; Lucarelli G
    Haematologica; 1994; 79(5):448-51. PubMed ID: 7843631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels.
    R'zik S; Loo M; Beguin Y
    Haematologica; 2001 Mar; 86(3):244-51. PubMed ID: 11255270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid profile in beta-thalassemia intermedia patients: correlation with erythroid bone marrow activity.
    Amendola G; Danise P; Todisco N; D'Urzo G; Di Palma A; Di Concilio R
    Int J Lab Hematol; 2007 Jun; 29(3):172-6. PubMed ID: 17474893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired iron-deficiency anemia caused by an antibody against the transferrin receptor.
    Larrick JW; Hyman ES
    N Engl J Med; 1984 Jul; 311(4):214-8. PubMed ID: 6330553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between soluble transferrin receptors in serum and membrane-bound transferrin receptors.
    Kuiper-Kramer EP; Coenen JL; Huisman CM; Abbes A; van Raan J; van Eijk HG
    Acta Haematol; 1998; 99(1):8-11. PubMed ID: 9490571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical importance of determining levels of circulating transferrin receptors in blood].
    Cermák J; Brabec V
    Vnitr Lek; 1999 Aug; 45(8):468-72. PubMed ID: 11045146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum transferrin receptor levels in beta-thalassemia trait.
    Demir A; Yarali N; Fisgin T; Duru F; Kara A
    J Trop Pediatr; 2004 Dec; 50(6):369-71. PubMed ID: 15537726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia.
    Mai A; Jelicic K; Rotili D; Di Noia A; Alfani E; Valente S; Altucci L; Nebbioso A; Massa S; Galanello R; Brosch G; Migliaccio AR; Migliaccio G
    Mol Pharmacol; 2007 Nov; 72(5):1111-23. PubMed ID: 17666592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.